跳至主要内容
临床试验/DRKS00005289
DRKS00005289已完成未知

Study on the evaluation of hippotherapy in the course of treatment for multiple sclerosis - a prospective, randomized controlled and multicenter study - MS-Hippo

Zentrum für Therapeutisches Reiten Johannisberg e.V.0 个研究点目标入组 70 人开始时间: 2013年10月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Definite multiple sclerosis with spasticity of the lower limbs;
  • EDSS-Score between 4 and 6.5;
  • Presence of an informed consent form signed by the patient;
  • Consent of the responsible investigator;
  • Legal capacity;
  • Minimum age of 18 years

排除标准

  • Hippotherapy within the last 12 months;
  • Parallel participation in other interventional studies;
  • Persons, who have an employment relationship/ a relationship of dependency on the sponsor or the investigator
  • Placing in an institution because of responsible governmental or judicial authorities;
  • Body weight above 90 kg;
  • Acute episode between 4 weeks prior to the start of the therapy;
  • No balance while sitting;
  • Planned start of an new spasmolytic drug or drugs, which could influence the tested parameters (for example Sativex®; Injection of Baclofen close to the spinal cord, 4-Aminopyridin);
  • cerebral seizure disorder, that is not medically adjusted;
  • No or insufficient ability to spread out the legs, which is necessary to sit on a horse;
  • Heavy osteoporosis;
  • Heavy arthrosis of the hip joint;
  • Heavy scoliosis, which could deteriorate under hippotherapy;
  • Heavy disorder of blood clotting, which increase the risk for bleedings because of hippotherapy
  • Unstable internal, gynaecological, surgical secondary illness;
  • Insurmountable fear of horses;
  • Allergy against horsehair;

研究者

发起方
Zentrum für Therapeutisches Reiten Johannisberg e.V.

相似试验